Tonix Pharmaceuticals Holdin

Biotech Stocks Healthcare Stocks

$16.34

+1.39 (+9.30%)

As of Feb 8, 2:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +149.3% upside

Low Target $28.14

Average Target $40.74

High Target $50.62

Current Price $16.34

Current
$16.34

Target
$40.74

$28.14 $40.74 avg $50.62

Scenario Analysis

Bear Case

$28.14

72.2%

Low target

Base Case

$40.74

+149.3%

Avg target

Bull Case

$50.62

+209.8%

High target

Risk/Reward

2.9x

Favorable

Price in Context

52-Week High

$44.54

-63.3% from high

52-Week Low

$30.30

+-46.1% from low

Target vs 52W High

$40.74

-8.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%